Literature DB >> 27515502

Lipopolysaccharide-induced preconditioning protects against traumatic spinal cord injury by upregulating Nrf2 expression in rats.

Weichao Li1, Dianming Jiang2, Qiuxia Li3, Shaoping Yao4, Xianrun Sun5, Yong Yang6, Zengdong Meng6, Wei Liu6.   

Abstract

AIMS: Lipopolysaccharide (LPS)-induced preconditioning protects neurons against traumatic spinal cord injury (TSCI) in rats. This study sought to test whether Nrf2, a transcription factor, mediated LPS-induced preconditioning. MAIN
METHODS: The TSCI model was established using a standardized NYU impactor on adult female rats. Rats were pretreated with LPS (0.2mg/kg, IP; 72h before injury). Nrf2 was silenced by injecting a lentivirus encoding RNAi against Nrf2 into injured spinal cords. Neurologic function was assessed by Basso, Beattie and Bresnahan (BBB) scores 6h, 12h, 24h, 48h, 72h, 7d and 14d after TSCI. Neuronal apoptosis was measured by a TUNEL staining. Ultrastructure was observed using transmission electron microscope (TEM). The protein expression of HO-1, NQO1 and GCLC was examined using immunohistochemistry and immunoblotting. KEY
FINDINGS: The injection of a lentivirus effectively transfected GFP into injured spinal cords. The expression of Nrf2 was significantly decreased in spinal cords receiving a lentivirus encoding RNAi against Nrf2. BBB scores showed that TSCI markedly impaired nervous function, which was markedly preserved by LPS pretreatment. Nrf2 knockdown significantly suppressed LPS pretreatment-induced protection of nervous function. TEM images and TUNEL staining showed an increase in apoptotic cells when Nrf2 was silenced. Moreover, immunohistochemistry and immunoblotting analysis exhibited that LPS pretreatment significantly upregulated the expression of anti-oxidative proteins including HO-1, NQO1 and GCLC, which was suppressed when Nrf2 expression was silenced in injured spinal cords. SIGNIFICANCE: LPS preconditioning effectively alleviates TSCI-induced impairment and preserves nervous function in a Nrf2-dependent manner.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anti–oxidant; Lipopolysaccharide; Nrf2; Traumatic spinal cord injury

Mesh:

Substances:

Year:  2016        PMID: 27515502     DOI: 10.1016/j.lfs.2016.08.008

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

Review 1.  LPS Preconditioning Attenuates Apoptosis Mechanism by Inhibiting NF-κB and Caspase-3 Activity: TLR4 Pre-activation in the Signaling Pathway of LPS-Induced Neuroprotection.

Authors:  Pushpa Gandi Sangaran; Zaridatul Aini Ibrahim; Zamri Chik; Zahurin Mohamed; Abolhassan Ahmadiani
Journal:  Mol Neurobiol       Date:  2021-01-09       Impact factor: 5.590

2.  Engagement of MicroRNA-155 in Exaggerated Oxidative Stress Signal and TRPA1 in the Dorsal Horn of the Spinal Cord and Neuropathic Pain During Chemotherapeutic Oxaliplatin.

Authors:  Fenghua Miao; Rong Wang; Guozhen Cui; Xiaoguang Li; Ting Wang; Xue Li
Journal:  Neurotox Res       Date:  2019-04-23       Impact factor: 3.911

3.  Peripheral viral challenge increases c-fos level in cerebral neurons.

Authors:  Tiffany J Petrisko; Gregory W Konat
Journal:  Metab Brain Dis       Date:  2021-08-18       Impact factor: 3.584

4.  Upregulation of heme oxygenase-1 protected against brain damage induced by transient cerebral ischemia-reperfusion injury in rats.

Authors:  Xiufang Lu; Renjun Gu; Weimin Hu; Zhitang Sun; Gaiqing Wang; Li Wang; Yuming Xu
Journal:  Exp Ther Med       Date:  2018-04-10       Impact factor: 2.447

5.  Trained Innate Immunity by Repeated Low-Dose Lipopolysaccharide Injections Displays Long-Term Neuroprotective Effects.

Authors:  Xiao-Yan Zhou; Rong Gao; Jian Hu; Da-Peng Gao; Yan-Ling Liao; Jian-Jun Yang
Journal:  Mediators Inflamm       Date:  2020-10-01       Impact factor: 4.711

6.  Serial Systemic Injections of Endotoxin (LPS) Elicit Neuroprotective Spinal Cord Microglia through IL-1-Dependent Cross Talk with Endothelial Cells.

Authors:  Camila M Freria; Faith H Brennan; David R Sweet; Zhen Guan; Jodie C Hall; Kristina A Kigerl; Daniel P Nemeth; Xiaoyu Liu; Steve Lacroix; Ning Quan; Phillip G Popovich
Journal:  J Neurosci       Date:  2020-10-13       Impact factor: 6.167

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.